I am a surgical breast oncologist whose practice is dedicated to the treatment of breast diseases. I strive to always give my patients compassionate care, both in the clinic and in the operating room, where I perform all aspects of breast cancer surgery, including breast conservation (lumpectomy), mastectomy, nipple-sparing mastectomy, and axillary lymph node procedures. I see patients at the Evelyn H. Lauder Breast Center in Manhattan, as well as at Memorial Sloan Kettering Commack. At both locations, I work closely with plastic surgeons, radiologists, and medical oncologists to ensure delivery of the highest-quality breast cancer care.
In addition to my clinical practice, I am actively involved in research that aims to continuously improve the care of our breast cancer patients. Some of my previous research has included work on the utilization of breast MRI for women with both invasive and in situ carcinoma and the appropriate surgical treatment for triple-negative breast cancers.
Currently, I am engaged in research to help personalize screening recommendations for women at high of developing breast cancer, working closely with MSK’s RISE program (Risk assessment, Imaging, Surveillance, and Education). My hope is that my research will enable us to deliver more individualized patient care and screening recommendations in the future. While many women in the RISE program do not require surgery, I counsel and treat women with high-risk breast lesions that do require excision, such as atypical ductal hyperplasia. I also work with many young women who have a genetic predisposition to breast cancer and are interested in undergoing bilateral prophylactic mastectomies for risk reduction.
Furthermore, I continue to study the appropriate management of ductal carcinoma in situ (DCIS), otherwise known as stage 0 breast cancer. DCIS is currently a controversial topic in medicine. I have worked with my colleagues to assess the risk of finding invasive cancer when surgery is performed for DCIS and to help predict the risk of a recurrence following our standard therapies. Our goal is to better define women with low-risk DCIS who may not require all aspects of breast cancer care. In addition, I am studying novel therapies such as topical medicine and exercise that may provide nontoxic treatment options for patients with DCIS or elevated breast cancer risk.
- Clinical Expertise: Breast Disease
- Languages Spoken: English
- Education: MD, Ohio State University College of Medicine
- Residencies: Northwestern University Feinberg School of Medicine
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: General Surgery
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more